Vyvanse vs. Kapvay: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Vyvanse and Kapvay. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 53,903 people who take Vyvanse and Kapvay, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.
What is Kapvay?
Kapvay has active ingredients of clonidine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 246 Kapvay users. Check the latest studies of Kapvay.
53,903 people who take Vyvanse and Kapvay are studied.
Drugs being compared in this study:
- Vyvanse (lisdexamfetamine dimesylate)
- Kapvay (clonidine hydrochloride)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Vyvanse:
- not at all: 1.94 %
- somewhat: 11.66 %
- moderate: 32.8 %
- high: 38.99 %
- very high: 14.61 %
Kapvay:
- not at all: 4.61 %
- somewhat: 25.03 %
- moderate: 37.02 %
- high: 22.0 %
- very high: 11.33 %
Want to compare Vyvanse with Kapvay?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Kapvay:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on lisdexamfetamine dimesylate and clonidine hydrochloride (the active ingredients of Vyvanse and Kapvay, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Antivert vs. Phenergan, side effect and effectiveness comparison - a second ago
- Drug interactions of Omnipaque 140 and Aspirin - 3 seconds ago
- Could Ditropan Xl cause Prostatic Specific Antigen Increased? - 8 seconds ago
- Could Zolmitriptan cause Hot Flush? - 36 seconds ago
- Could Requip cause Oxygen Saturation Decreased? - 54 seconds ago
- Upper Respiratory Tract Infection and Blood Potassium Decreased - a minute ago
- Could Atorvastatin Calcium cause Conjunctivitis? - a minute ago
- Glioma and Weight Increased - a minute ago
- Could Ifosfamide cause Leukoencephalopathy? - a minute ago
- Drug interactions of Nourianz and Oxycodone - a minute ago